Anti-Serpin-B11 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the amino-terminal region of mature human Serpin-B11, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Pan, Monkey, Dog
UniProt
Q96P15
Size
100ug
Cat. #
RP2SerpinB11

In stock

SKU
RP-SerpinB11

Options

As low as: $130.00

Target Overview

Serpin-B11 (SERPINB11, UniProt Q96P15) is a 392-residue member of the clade B serpin superfamily localized to the cytoplasm. Unlike most serpins, Serpin-B11 lacks canonical serine protease inhibitory activity due to structural variants in the scaffold that prevent the conformational changes required for protease inhibition. The gene is expressed in select epithelial tissues and has been implicated in diverse pathophysiological contexts, including ovarian cancer, acute liver injury, and prostate cancer biomarker panels. While its precise biochemical function remains incompletely characterized, emerging evidence suggests roles in cell death regulation, calcium homeostasis, and stress responses independent of classic protease inhibition. Researchers studying clade B serpin biology, epithelial cell signaling, or disease-associated serpin variants rely on specific detection of Serpin-B11 to distinguish it from the 12 other human SERPINB family members, many of which share considerable sequence homology.

Background

Serpin-B11 has emerged as a protein of interest in several clinical and experimental contexts despite its lack of protease inhibitory function. Park et al. (2021) reported that SERPINB11 expression correlates with prognosis in high-grade serous and clear cell carcinoma of the ovary, with immunohistochemical staining revealing differential expression patterns associated with patient outcomes. The protein has been further implicated in ovarian cancer cell death pathways, where its inhibition was shown to enhance calcium influx through ER-mitochondria signaling axes. Beyond oncology, genetic variants in SERPINB11 have been linked to acute liver injury. Umman et al. (2022) described SERPINB11 variant-related liver injury in the context of Shiga toxin-producing E. coli hemolytic uremic syndrome (STEC-HUS), and whole exome sequencing studies of indeterminate acute liver failure cases have identified SERPINB11 mutations as candidate genetic contributors. The protein has also appeared in genomic classifier panels for prostate cancer, where it is included among genes used to predict biochemical recurrence risk following prostatectomy. These diverse associations suggest that Serpin-B11 may function as a stress-response or tissue-protective factor whose loss or dysregulation contributes to cellular injury in specific epithelial compartments. The lack of protease inhibitor activity distinguishes Serpin-B11 from canonical serpins and raises questions about alternative mechanisms, potentially involving protein-protein interactions or scaffolding roles that remain to be fully elucidated.

References

  1. Park SJ et al (2021) SERPINB11 Expression Is Associated With Prognosis of High-grade Serous and Clear Cell Carcinoma of the Ovary. In Vivo. PubMed · 10.21873/invivo.12547
  2. Umman N et al (2022) SERPINB11 variant-related liver injury in STEC-HUS: case reports and literature review. Pediatr Nephrol. PubMed · 10.1007/s00467-022-05602-5
  3. Lee JY et al (2020) Eupatilin Promotes Cell Death by Calcium Influx through ER-Mitochondria Axis with SERPINB11 Inhibition in Epithelial Ovarian Cancer. Cancers (Basel). PubMed · 10.3390/cancers12061459
  4. Rakela J et al (2019) Whole Exome Sequencing Among 26 Patients With Indeterminate Acute Liver Failure: A Pilot Study. Clin Transl Gastroenterol. PubMed · 10.14309/ctg.0000000000000087
  5. Treacy PJ et al (2023) Decipher Score predicts prostate specific antigen persistence after prostatectomy. Minerva Urol Nephrol. PubMed · 10.23736/S2724-6051.23.05395-8

Additional Specifications

Gene Symbol SerpinB11
UniProt ID Q96P15
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Amino end mature Serpin-B11)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-51.
Immunogen (Reactive Center Loop (RCL))Immunogen is proprietary and confidential. Immunogen generated in amino acid region 341-365.
Alternate Names Serpin B11, SERPINB11

Frequently Asked Questions

What molecular weight should I expect for Serpin-B11 on Western blot?

Serpin-B11 (UniProt Q96P15) is a 392-amino-acid protein with a predicted molecular weight of approximately 42-43 kDa. On reducing SDS-PAGE, the band typically migrates near this range, though minor variations can occur depending on post-translational modifications or sample preparation. Because Serpin-B11 is a cytoplasmic protein lacking a signal peptide and is not glycosylated in most contexts, you should see a single, relatively sharp band. If you observe multiple bands, consider protease activity during lysis or potential splice variants, though the dominant isoform is well-characterized. Start your Western at 1:1000 dilution.

Does this Serpin-B11 antibody cross-react with other clade B serpins?

Clade B serpins share substantial sequence homology, particularly within the serpin domain scaffold, so cross-reactivity is a valid concern. This rabbit polyclonal was raised against a Serpin-B11-specific epitope region and validated on human samples. We have not observed cross-reactivity with closely related family members such as Serpin-B3, B4, or B12 in our validation panels, but we recommend including lysates from cells or tissues with known high expression of related serpins as negative or competition controls if specificity is critical to your experimental interpretation. Predicted cross-reactivity with primate orthologs is based on sequence conservation.

Which human tissues or cell lines express Serpin-B11 for positive control samples?

Serpin-B11 expression is restricted to select epithelial tissues. Ovarian carcinoma cell lines and certain prostate cancer specimens have demonstrated robust expression in published datasets, making them suitable positive controls. Normal tissue expression is relatively low and confined to stratified epithelia. If you lack access to cancer lines, consider using ovarian or prostate tissue lysates. For negative controls, hematopoietic cells or fibroblasts typically show minimal to undetectable Serpin-B11. Because the antibody targets an intracellular antigen, whole-cell lysates in RIPA or similar buffers work well. Avoid relying solely on predicted expression; empirical validation with your sample type is advisable.

What starting dilution and blocking conditions work best for Serpin-B11 Western blots?

Start at 1:1000 dilution in Tris-buffered saline with 0.1 percent Tween-20 and 5 percent non-fat dry milk or BSA. Serpin-B11 is a moderately abundant cytoplasmic protein in expressing tissues, so signal should be detectable within this range. Block membranes for one hour at room temperature. Because the antibody is a rabbit polyclonal, background can vary by lot and sample complexity; if you see high background, try increasing the dilution to 1:2000 or switching to BSA if using milk. Incubate overnight at 4°C for optimal sensitivity. Use a standard HRP-conjugated anti-rabbit secondary at the manufacturer's recommended dilution.

Can I use this antibody for immunofluorescence or IHC on human samples?

Yes. Triple Point Biologics antibodies are routinely validated for immunohistochemistry and immunofluorescence in addition to Western blot. For IHC on formalin-fixed paraffin-embedded sections, antigen retrieval is typically required; citrate buffer at pH 6.0 with heat-induced epitope retrieval is a reasonable starting point. For immunofluorescence, Serpin-B11 is cytoplasmic, so permeabilization with 0.1–0.3 percent Triton X-100 is essential. Start dilutions around 1:100 to 1:200 and titrate. Because expression is epithelial and often focal, include known positive tissue or cell controls to confirm staining specificity and avoid overinterpretation of weak signal.

Is this Serpin-B11 antibody likely to work in dog or non-human primate samples?

The antibody is validated on human samples and shows potential cross-reactivity with monkey and dog based on sequence homology in the epitope region. Primate orthologs share greater than 85 percent identity with human Serpin-B11, so cross-reactivity is predicted to be strong. Canine Serpin-B11 is less well characterized, and homology is moderate; empirical testing is recommended. If working with these species, run a dilution series starting at 1:500 and include a human positive control on the same blot to benchmark signal intensity. We have not formally validated these reactivities, so consider them preliminary until you confirm performance in your system.

How should I store the antibody and what is the expected shelf life?

Store the antibody at -20°C in single-use aliquots to avoid freeze-thaw cycles, which can reduce titer and increase aggregation. The 100 µg pack size is supplied in a glycerol-containing buffer that remains stable for at least two years at -20°C. Once thawed, an aliquot can be held at 4°C for up to one month for convenience during active experiments, but repeated freeze-thaw will degrade performance. Do not store diluted antibody in working solutions for more than one week. If you observe increased background or loss of signal over time, prepare a fresh aliquot. Sodium azide at 0.02 percent can be added as a preservative for 4°C storage.

Why does Serpin-B11 lack protease inhibitory activity despite being a serpin?

Serpin-B11 belongs to a subset of clade B serpins that have evolved away from canonical serine protease inhibition. The reactive center loop and hinge region contain structural variants that prevent the dramatic conformational change required to trap a protease in a covalent acyl-enzyme intermediate. This loss of inhibitory function is not unique; several clade B members, including Serpin-B3 and B4, are non-inhibitory. Current evidence suggests Serpin-B11 instead functions in cell death regulation, calcium handling, or stress signaling through mechanisms independent of protease inhibition. When interpreting your data, do not assume Serpin-B11 regulates proteolytic cascades directly.

Western blot validation for RP-SerpinB11 — 1 panel across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Serpin-B11: Amino end mature Serpin-B11 — WB validation
WB · Panel 1 Serpin-B11: Amino end mature Serpin-B11

Custom validation studies available on request — contact us.

Also known as:

  • Serpin B11
  • SERPINB11
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →